Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07350382
What this trial is testing

Predicting Cognitive Dysfunction After Pediatric Posterior Fossa Tumor Surgery

Who this might be right for
Posterior Fossa TumorsPediatric Tumor of Brain
West China Hospital 600
Not applicableEnded earlyNCT03515603
What this trial is testing

Endocrine Outcome of Surgery for Pituitary Adenoma

Who this might be right for
Pituitary Adenoma
University of Ulm 36
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Not applicableStudy completedNCT03336762
What this trial is testing

Injured Spinal Cord Pressure Evaluation Study - Transverse Myelitis

Who this might be right for
Transverse Myelitis
St George's, University of London 1
Early research (Phase 1)Looking for participantsNCT05366179
What this trial is testing

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Who this might be right for
Glioblastoma Multiforme
UNC Lineberger Comprehensive Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT01868269
What this trial is testing

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Who this might be right for
Opsoclonus Myoclonus SyndromeNeuroblastoma
Institut Curie 102
Not applicableLooking for participantsNCT02824731
What this trial is testing

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Who this might be right for
Brain Tumors
Technische Universität Dresden 555
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06441045
What this trial is testing

Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI

Who this might be right for
Leptomeningeal Metastasis
Fujian Cancer Hospital 112
Large-scale testing (Phase 3)Study completedNCT00003375
What this trial is testing

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 370
Testing effectiveness (Phase 2)UnknownNCT00360945
What this trial is testing

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 87
Testing effectiveness (Phase 2)Study completedNCT01218529
What this trial is testing

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Who this might be right for
Brain MetastasesLung TumorsBreast Tumors
Hellenic Cooperative Oncology Group 82
Not applicableUnknownNCT05126875
What this trial is testing

Re-TREAT: Re-irradiation for Relapsed Brain Metastases

Who this might be right for
CancerBrain Metastases, Adult
Rigshospitalet, Denmark 44
Not applicableStudy completedNCT00042445
What this trial is testing

Brain Neoplasms, Leukemia and Petrochemical Exposures

Who this might be right for
LeukemiaBrain Neoplasm
National Institute of Environmental Health Sciences (NIEHS) 1,456
Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Not applicableUnknownNCT02803619
What this trial is testing

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal Metastasis
Peking Union Medical College Hospital 60
Post-approval studies (Phase 4)Enrolling By InvitationNCT02670161
What this trial is testing

Quality Improvement and Practice Based Research in Neurology Using the EMR

Who this might be right for
Brain TumorsEpilepsyMigraine+7 more
Endeavor Health 3,300
Not applicableLooking for participantsNCT04699773
What this trial is testing

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

Who this might be right for
GliomaGlioblastomaBrain Tumor
University of Maryland, Baltimore 32
Not applicableNot Yet RecruitingNCT07732140
What this trial is testing

Listen Aphasia Pilot Study

Who this might be right for
AphasiaMalignant Brain Tumor
Dana-Farber Cancer Institute 80
Next Page